If there is a strong suspicion of lymphocytic hypophysitis and there is no visual loss, then corticosteroid therapy is usually given as first-line management. It is important to measure IgG4 ...

With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

In a Diabetes Remission Clinical Trial (DiRECT), researchers randomized participants into one of two groups: weight management and pharmacological therapy. They found that 46% of the participants ...

A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Feb. 12, 2025 — People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually ...

Getting to know what’s going on in your body can help you manage type 2 diabetes well ... They can aid blood sugar management and help keep you feeling fuller for longer to help prevent mindless ...

She combines her writing skills with her experience in personal wealth management. Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from ...

The rapid evolution of diabetes research and management calls for a forward-thinking approach that embraces innovation to address the multifaceted ...

†High patient compliance after training. ‡Likely to be preferred for frail patients. Adapted from [34].